Indian firms ab bahar ki companiyon ko kharidne mein lage hain taaki supply chain secure rahe. 2026 mein outbound deals **$24 Billion** tak pahunch gayi hain, jabki domestic IPOs gir kar sirf **$9.9 Billion** reh gaye hain.
India Inc. ka Global Strategy Change
Indian companies ab apne comfort zone se bahar nikal rahi hain. 2026 ke pehle 6 mahino mein Indian firms ne $24 Billion ki overseas acquisitions ki hain. Iska main maqsad hai energy assets aur critical minerals par seedha control paana, taaki global trade ke jhatke unhe affect na karein.
Sun Pharma ka bada deal
Is trend ka bada example Sun Pharmaceuticals hai, jinhone US-based Organon & Co ko $11.75 Billion mein kharidne ka deal kiya hai. Lekin investors ko alert rehna hoga—itni badi buying ke liye jo debt liya jata hai, agar uska sahi management nahi hua, toh profit margins par pressure aa sakta hai.
IPO Market ka kya haal hai?
Ek taraf bahar deals ho rahi hain, toh wahi domestic IPO market kaafi thanda pada hai. September 2026 tak sirf $9.9 Billion hi raise ho paaye hain, jo pichle saal ke $21.8 Billion ke muqable bohot kam hai. Companies shayad acche market conditions ka wait kar rahi hain.
Agla bada move?
Market abhi bhi kuch bade listings ka intezaar kar raha hai. National Stock Exchange aur Reliance Jio Platforms ki IPOs agar aati hain, toh market mein fir se raunak laut sakti hai. Investors ke liye agle kuch mahine crucial rahenge, ye dekhne ke liye ki kya ye badi overseas purchases sach mein long-term growth layengi.